Symptoms And Signs Of Maple Syrup Urine Disease
Published on: December 18, 2024
Symptoms and Signs of Maple Syrup Urine Disease
  • Article reviewer photo

    Taniya Jose

    MEng Biomedical Engineering, University of Glasgow

Introduction

Brief overview of Maple Syrup Urine Disease (MSUD)

A rare hereditary condition called Maple Syrup Urine Disease (MSUD) impairs the body's capacity to metabolise certain amino acids. Proteins are made up of amino acids, some of which are referred to as branched-chain amino acids (BCAAs). These amino acids include valine, isoleucine, and leucine. Because of a defective or absent enzyme, the body is unable to effectively break down certain amino acids in individuals with MSUD. Consequently, there is an accumulation of these amino acids and their byproducts in the urine and blood, which can lead to major health issues. The disease's eponymous sweet smell—reminiscent of maple syrup—in the urine of afflicted patients is one of the most obvious indicators of multiple system dysfunction.

Given that MSUD is an autosomal recessive disorder, a child can only get the illness if they receive one defective gene from each parent. Multiple sclerosis (MSUD) manifests in several forms, with the most severe form emerging soon after birth and lesser variants potentially developing later in life.1, 2

Importance of recognising symptoms and signs early

Early diagnosis and treatment of MSUD symptoms are critical since they can avert serious health problems. The accumulation of dangerous compounds in the blood can cause major issues, including brain damage, developmental delays, and even death if MSUD is not treated promptly.3,4

Babies undergoing newborn screening tests, performed soon after birth, are able to identify MSUD before symptoms manifest. This makes it possible to start therapy right away, which typically entails following a particular diet that restricts the intake of the troublesome amino acids. Doctors can help avoid the disease's harmful consequences by controlling the diet and occasionally prescribing supplements.3,4

Early signs of MSUD, such as poor eating, vomiting, excessive tiredness, and distinctively sweet-smelling urine, should be known to parents and other carers. By identifying these symptoms early on, doctors can diagnose and treat children more quickly, increasing their chances of a long, healthy life.4,5

Early symptoms

Poor feeding

  • Refusal to eat - Poor nutrition may result from a baby's frequent refusal to feed when they have MSUD7 
  • Difficulty in feeding - They may find it difficult to swallow or suck, even when they make an effort8

Vomiting

  • Frequent episodes - Frequent vomiting is a common early sign of multiple sclerosis6 
  • Impact on hydration and nutrition - Vomiting causes the loss of vital nutrients and fluids, which results in dehydration and weakness8
  • LethargyUnusual sleepiness - Infants suffering from Multiple Sclerosis may have excessive drowsiness and difficulty waking up6
  • Lack of energy - They frequently seem extremely exhausted and are unable to react or move8

Maple syrup odour in urine

  • Distinct sweet smell - Urine with a distinct sweet scent is one of the most prominent indicators of MSUD7
  • Early diagnostic clue - This distinctive odour is a critical clue for detecting the disease quickly8

Neurological symptoms

Seizures

  • Types of seizures observed - Multiple sclerosis (MSUD) has been linked to a number of seizure forms, including metabolic seizures, which are frequently brought on by the body's incapacity to correctly digest specific chemicals. Unusual movements or unconsciousness are two possible symptoms of these seizures9
  • Frequency and duration - Seizures with MSUD can occur more frequently and last longer, though. They can be frequent, starting in the early years of life, and need continuous care to stop more brain damage9

Developmental delays

  • Delayed milestones - Children with MSUD may take longer to accomplish milestones including sitting, crawling, and walking9
  • Impact on motor skills and cognition - These delays may have an impact on a person's cognitive and motor capabilities. Children may grow more slowly overall if they take longer to learn how to move and interact with their surroundings8

Abnormal movements

  • Hypertonia (increased muscle tone) - A condition marked by elevated muscular tone, hypertonia can result in stiffness and trouble moving. Uncontrollable movements and strange postures may result from this10
  • Hypotonia (decreased muscle tone) - Children with hypotonia have weak muscles and floppiness, which makes it difficult for them to maintain proper posture and regulate their movements. This state is frequently seen in neurological conditions such as MSUD11

Severe symptoms in untreated cases

Coma

  • Progression from lethargy - If MSUD is left untreated, a child may experience progressive lethargy, which is characterised by growing drowsiness and lack of responsiveness. A coma, which is a profound unconsciousness in which the kid is not responsive to stimuli and cannot be roused, may result from this12
  • Risk factors and indicators - A coma's likelihood to worsen is mostly dependent on how severe the metabolic imbalance is and how long treatment is delayed. Severe lethargic episodes, disorientation, and notable alterations in awareness and receptiveness are warning signs of an approaching coma12 

Respiratory failure

1Breathing difficulties - As the illness becomes worse, the metabolic disruptions may make it more difficult for the brain to regulate breathing, which can result in respiratory failure. Breathing too quickly, having trouble breathing, and having blue skin from low oxygen levels are some of the symptoms.12

Potential need for ventilation support - Mechanical ventilation could be necessary in extreme circumstances to help with breathing. In order to ensure proper oxygenation and carbon dioxide removal from the lungs, a machine is used to flow air in and out of the lungs.12

Swelling of the brain (cerebral oedema)

Symptoms indicating increased intracranial pressure - Brain swelling, or cerebral oedema, can result in elevated intracranial pressure (ICP). Severe headache, nausea, impaired vision, and a changed mental state are some of the symptoms. Cushing's triad—hypertension (high blood pressure), bradycardia (slow heart rate), and erratic breathing—is a classic indicator of elevated ICP.6

Diagnostic methods - Imaging investigations and clinical examination are required for the diagnosis of elevated ICP. Brain swelling and other anomalies can be seen using CT or MRI imaging. It could occasionally be required to measure the ICP directly with specialised equipment.7

Long-term complications

Intellectual disability

  • Cognitive impairment - Major cognitive deficits impacting memory, problem-solving, and other executive processes may be experienced by people with MSUD3,7
  • Learning difficulties - Students with MSUD frequently experience difficulties in the classroom, such as delays in meeting developmental milestones and challenges completing assignments, necessitating additional educational help4,5

Behavioural issues

  • Hyperactivity - It can be challenging to learn and engage socially with others when someone exhibits hyperactive behaviours, which are frequent and have symptoms similar to ADHD, such as trouble sitting still and impulsivity4,7
  • Attention deficits - Specific instructional practices are required since attention problems make it difficult to focus, finish tasks, and follow directions3,10

Diagnosis

Newborn screening

Importance and methods - Early diagnosis of serious genetic abnormalities, such as Maple Syrup Urine Disease (MSUD), is mostly dependent on newborn screening. Timely intervention, made possible by early detection, can greatly lower morbidity and death. A heel prick blood test is one of the techniques used, and the sample is examined for certain metabolites and enzyme activity that may indicate metabolic abnormalities.13

Biochemical testing (amino acid levels) - Analysing blood levels of amino acids is a component of biochemical testing (Amino Acid Levels). Elevated leucine, isoleucine, and valine levels are commonly seen in MSUD. When a newborn screening test yields a positive result initially, more testing is necessary to confirm the diagnosis. For these studies, methods like tandem mass spectrometry are frequently employed.14

Genetic testing

Identification of mutations - To find mutations in the DBT, BCKDHA, and BCKDHB genes, genetic testing entails sequencing the genes linked to MSUD. The defective enzyme complex that breaks down branched-chain amino acids is the result of these mutations. Certain mutations can be identified to support the diagnosis and direct therapeutic approaches.13,14 

Family history considerations - Since MSUD is an inherited condition with an autosomal recessive pattern, knowledge of the family history is crucial to the diagnosis. In addition to offering information on inheritance patterns and their implications for other family members, genetic counselling can assist in determining the likelihood of future pregnancies. Families with a known history of the illness must take this into account.13,14

FAQ’s

What are the initial signs and symptoms of babies with Maple Syrup Urine Disease (MSUD)?

Lethargy, poor eating, irritability, vomiting, and a sweet, syrupy scent in perspiration and urine are some of the early signs.

Should MSUD be left untreated, what serious symptoms can appear?

Seizures, hypotonia, coma, and developmental abnormalities can result from MSUD if left untreated.

Other than the sweet-smelling urine, are there any other tell-tale symptoms of MSUD?

Yes, there are other symptoms as well, including a high-pitched scream, aberrant movements, low-weight growth, and muscular weakness. 

Summary


A dangerous metabolic condition known as Maple Syrup Urine Disease (MSUD) is characterised by a variety of symptoms that usually manifest in the first few days or weeks of birth. The presence of a particularly sweet smell in the perspiration (sweat) and urine (similar to maple syrup), lethargy, poor eating, vomiting, and developmental delays are important warning signs. Seizures, strange movements, mental impairment, and other serious neurological problems might result from MSUD if treatment is not received. Improving results and the quality of life for those who are afflicted requires early identification and care.

References

Share

Ayushi Vira

Masters of Clinical Research , Clinical research, The University of Sheffield

Ayushi Vira is a clinical research professional with a strong pharmaceutical background, holding a degree from the University of Mumbai and an MSc in Clinical Research from the University of Sheffield. Her expertise spans drug safety analysis, data management, and patient recruitment, bolstered by certifications in Good Clinical Practice and Pharmacovigilance.

As a medical writer for Klarity and a researcher at the University of Sheffield, Ayushi has led discussion groups, published critical research findings, and conducted clinical trials. She excels in creating digital health content, data visualization, and enhancing patient recruitment strategies.

Fluent in several languages, Ayushi is dedicated to advancing the pharmaceutical industry through innovative research and effective patient engagement.Her dedication to these areas fulfils her passion to provide medical information that promotes global health.

arrow-right